HEADER HYDROLASE/HYDROLASE INHIBITOR 11-MAR-15 4YOG TITLE HKU4-3CLPRO BOUND TO NON-COVALENT INHIBITOR 3B COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO, 3CLP; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BAT CORONAVIRUS HKU4; SOURCE 3 ORGANISM_COMMON: BTCOV; SOURCE 4 ORGANISM_TAXID: 694007; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HKU4 3CLPRO MPRO NSP5, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.ST JOHN,A.MESECAR REVDAT 5 28-FEB-24 4YOG 1 REMARK REVDAT 4 11-DEC-19 4YOG 1 REMARK REVDAT 3 20-SEP-17 4YOG 1 JRNL REMARK REVDAT 2 09-SEP-15 4YOG 1 JRNL REVDAT 1 05-AUG-15 4YOG 0 JRNL AUTH S.E.ST JOHN,S.TOMAR,S.R.STAUFFER,A.D.MESECAR JRNL TITL TARGETING ZOONOTIC VIRUSES: STRUCTURE-BASED INHIBITION OF JRNL TITL 2 THE 3C-LIKE PROTEASE FROM BAT CORONAVIRUS HKU4-THE LIKELY JRNL TITL 3 RESERVOIR HOST TO THE HUMAN CORONAVIRUS THAT CAUSES MIDDLE JRNL TITL 4 EAST RESPIRATORY SYNDROME (MERS). JRNL REF BIOORG.MED.CHEM. V. 23 6036 2015 JRNL REFN ESSN 1464-3391 JRNL PMID 26190463 JRNL DOI 10.1016/J.BMC.2015.06.039 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1692) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 38445 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.5512 - 4.8097 0.99 2842 156 0.1514 0.1642 REMARK 3 2 4.8097 - 3.8205 1.00 2732 150 0.1241 0.1929 REMARK 3 3 3.8205 - 3.3384 0.99 2682 148 0.1533 0.1709 REMARK 3 4 3.3384 - 3.0335 0.99 2654 145 0.1672 0.2046 REMARK 3 5 3.0335 - 2.8163 0.98 2619 144 0.1740 0.2243 REMARK 3 6 2.8163 - 2.6504 0.97 2567 141 0.1797 0.2262 REMARK 3 7 2.6504 - 2.5177 0.97 2567 141 0.1893 0.2370 REMARK 3 8 2.5177 - 2.4082 0.97 2576 141 0.1904 0.2432 REMARK 3 9 2.4082 - 2.3155 0.97 2576 141 0.1892 0.2524 REMARK 3 10 2.3155 - 2.2357 0.97 2573 142 0.1857 0.2526 REMARK 3 11 2.2357 - 2.1658 0.97 2563 140 0.1938 0.2436 REMARK 3 12 2.1658 - 2.1039 0.97 2561 140 0.2066 0.2756 REMARK 3 13 2.1039 - 2.0485 0.96 2531 140 0.2293 0.2430 REMARK 3 14 2.0485 - 2.0000 0.91 2402 131 0.2580 0.3256 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.450 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4934 REMARK 3 ANGLE : 1.086 6732 REMARK 3 CHIRALITY : 0.042 765 REMARK 3 PLANARITY : 0.005 868 REMARK 3 DIHEDRAL : 13.554 1710 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YOG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1000207836. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39549 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 28.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.82 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG-3350, 0.2 M AMMONIUM ACETATE, REMARK 280 0.1 M BIS-TRIS PH 5.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.89950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.49550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.76700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.49550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.89950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.76700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24990 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE B 143 O HOH B 501 2.04 REMARK 500 OD2 ASP A 55 O HOH A 501 2.16 REMARK 500 OD1 ASN A 53 O HOH A 501 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 501 O HOH B 524 1455 2.02 REMARK 500 O HOH A 516 O HOH B 502 1455 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 27 -168.02 -161.86 REMARK 500 ASP A 33 -133.82 51.19 REMARK 500 ALA A 74 90.02 -66.20 REMARK 500 ALA A 187 59.12 -94.09 REMARK 500 LYS A 220 13.84 -142.93 REMARK 500 ASP B 33 -127.01 50.48 REMARK 500 ALA B 74 97.79 -66.99 REMARK 500 GLN B 192 -72.11 -64.67 REMARK 500 THR B 193 104.63 -0.61 REMARK 500 LYS B 220 14.12 -147.07 REMARK 500 MET B 305 -169.11 -79.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4F5 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4F5 B 404 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4YOI RELATED DB: PDB REMARK 900 RELATED ID: 4YO9 RELATED DB: PDB REMARK 900 RELATED ID: 4YOJ RELATED DB: PDB DBREF 4YOG A 1 306 UNP P0C6W3 R1AB_BCHK4 3292 3597 DBREF 4YOG B 1 306 UNP P0C6W3 R1AB_BCHK4 3292 3597 SEQRES 1 A 306 SER GLY LEU VAL LYS MET SER ALA PRO SER GLY ALA VAL SEQRES 2 A 306 GLU ASN CYS ILE VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 A 306 ARG HIS ILE MET CYS PRO ALA ASP GLN LEU THR ASP PRO SEQRES 5 A 306 ASN TYR ASP ALA LEU LEU ILE SER LYS THR ASN HIS SER SEQRES 6 A 306 PHE ILE VAL GLN LYS HIS ILE GLY ALA GLN ALA ASN LEU SEQRES 7 A 306 ARG VAL VAL ALA HIS SER MET VAL GLY VAL LEU LEU LYS SEQRES 8 A 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 A 306 THR PHE SER THR VAL LYS PRO GLY ALA SER PHE SER VAL SEQRES 10 A 306 LEU ALA CYS TYR ASN GLY LYS PRO THR GLY VAL PHE THR SEQRES 11 A 306 VAL ASN LEU ARG HIS ASN SER THR ILE LYS GLY SER PHE SEQRES 12 A 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR GLU ASN SEQRES 13 A 306 GLY GLY VAL ILE ASN PHE VAL TYR MET HIS GLN MET GLU SEQRES 14 A 306 LEU SER ASN GLY THR HIS THR GLY SER SER PHE ASP GLY SEQRES 15 A 306 VAL MET TYR GLY ALA PHE GLU ASP LYS GLN THR HIS GLN SEQRES 16 A 306 LEU GLN LEU THR ASP LYS TYR CYS THR ILE ASN VAL VAL SEQRES 17 A 306 ALA TRP LEU TYR ALA ALA VAL LEU ASN GLY CYS LYS TRP SEQRES 18 A 306 PHE VAL LYS PRO THR ARG VAL GLY ILE VAL THR TYR ASN SEQRES 19 A 306 GLU TRP ALA LEU SER ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 A 306 THR GLN SER ILE ASP MET LEU ALA HIS ARG THR GLY VAL SEQRES 21 A 306 SER VAL GLU GLN MET LEU ALA ALA ILE GLN SER LEU HIS SEQRES 22 A 306 ALA GLY PHE GLN GLY LYS THR ILE LEU GLY GLN SER THR SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO ASP ASP VAL ASN MET GLN SEQRES 24 A 306 VAL MET GLY VAL VAL MET GLN SEQRES 1 B 306 SER GLY LEU VAL LYS MET SER ALA PRO SER GLY ALA VAL SEQRES 2 B 306 GLU ASN CYS ILE VAL GLN VAL THR CYS GLY SER MET THR SEQRES 3 B 306 LEU ASN GLY LEU TRP LEU ASP ASN THR VAL TRP CYS PRO SEQRES 4 B 306 ARG HIS ILE MET CYS PRO ALA ASP GLN LEU THR ASP PRO SEQRES 5 B 306 ASN TYR ASP ALA LEU LEU ILE SER LYS THR ASN HIS SER SEQRES 6 B 306 PHE ILE VAL GLN LYS HIS ILE GLY ALA GLN ALA ASN LEU SEQRES 7 B 306 ARG VAL VAL ALA HIS SER MET VAL GLY VAL LEU LEU LYS SEQRES 8 B 306 LEU THR VAL ASP VAL ALA ASN PRO SER THR PRO ALA TYR SEQRES 9 B 306 THR PHE SER THR VAL LYS PRO GLY ALA SER PHE SER VAL SEQRES 10 B 306 LEU ALA CYS TYR ASN GLY LYS PRO THR GLY VAL PHE THR SEQRES 11 B 306 VAL ASN LEU ARG HIS ASN SER THR ILE LYS GLY SER PHE SEQRES 12 B 306 LEU CYS GLY SER CYS GLY SER VAL GLY TYR THR GLU ASN SEQRES 13 B 306 GLY GLY VAL ILE ASN PHE VAL TYR MET HIS GLN MET GLU SEQRES 14 B 306 LEU SER ASN GLY THR HIS THR GLY SER SER PHE ASP GLY SEQRES 15 B 306 VAL MET TYR GLY ALA PHE GLU ASP LYS GLN THR HIS GLN SEQRES 16 B 306 LEU GLN LEU THR ASP LYS TYR CYS THR ILE ASN VAL VAL SEQRES 17 B 306 ALA TRP LEU TYR ALA ALA VAL LEU ASN GLY CYS LYS TRP SEQRES 18 B 306 PHE VAL LYS PRO THR ARG VAL GLY ILE VAL THR TYR ASN SEQRES 19 B 306 GLU TRP ALA LEU SER ASN GLN PHE THR GLU PHE VAL GLY SEQRES 20 B 306 THR GLN SER ILE ASP MET LEU ALA HIS ARG THR GLY VAL SEQRES 21 B 306 SER VAL GLU GLN MET LEU ALA ALA ILE GLN SER LEU HIS SEQRES 22 B 306 ALA GLY PHE GLN GLY LYS THR ILE LEU GLY GLN SER THR SEQRES 23 B 306 LEU GLU ASP GLU PHE THR PRO ASP ASP VAL ASN MET GLN SEQRES 24 B 306 VAL MET GLY VAL VAL MET GLN HET ACT A 401 4 HET ACT A 402 4 HET ACT A 403 4 HET ACT A 404 4 HET 4F5 A 405 36 HET ACT B 401 4 HET ACT B 402 4 HET ACT B 403 4 HET 4F5 B 404 36 HETNAM ACT ACETATE ION HETNAM 4F5 N-[4-(ACETYLAMINO)PHENYL]-2-(1H-BENZOTRIAZOL-1-YL)-N- HETNAM 2 4F5 [(1R)-2-(TERT-BUTYLAMINO)-2-OXO-1-(THIOPHEN-3-YL) HETNAM 3 4F5 ETHYL]ACETAMIDE FORMUL 3 ACT 7(C2 H3 O2 1-) FORMUL 7 4F5 2(C26 H28 N6 O3 S) FORMUL 12 HOH *222(H2 O) HELIX 1 AA1 SER A 10 ASN A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 PRO A 45 LEU A 49 5 5 HELIX 4 AA4 ASN A 53 LYS A 61 1 9 HELIX 5 AA5 THR A 62 HIS A 64 5 3 HELIX 6 AA6 LEU A 144 CYS A 148 5 5 HELIX 7 AA7 CYS A 203 ASN A 217 1 15 HELIX 8 AA8 GLY A 229 ASN A 240 1 12 HELIX 9 AA9 THR A 248 GLY A 259 1 12 HELIX 10 AB1 SER A 261 GLY A 275 1 15 HELIX 11 AB2 THR A 292 VAL A 300 1 9 HELIX 12 AB3 SER B 10 ASN B 15 1 6 HELIX 13 AB4 HIS B 41 CYS B 44 5 4 HELIX 14 AB5 ALA B 46 THR B 50 5 5 HELIX 15 AB6 ASN B 53 LYS B 61 1 9 HELIX 16 AB7 THR B 62 HIS B 64 5 3 HELIX 17 AB8 LEU B 144 CYS B 148 5 5 HELIX 18 AB9 MET B 184 PHE B 188 5 5 HELIX 19 AC1 CYS B 203 LEU B 216 1 14 HELIX 20 AC2 GLY B 229 LEU B 238 1 10 HELIX 21 AC3 THR B 248 GLY B 259 1 12 HELIX 22 AC4 SER B 261 GLY B 275 1 15 HELIX 23 AC5 THR B 292 GLN B 299 1 8 SHEET 1 AA1 7 ALA A 76 LEU A 78 0 SHEET 2 AA1 7 PHE A 66 LYS A 70 -1 N VAL A 68 O LEU A 78 SHEET 3 AA1 7 ILE A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 MET A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 THR A 35 PRO A 39 -1 O TRP A 37 N LEU A 30 SHEET 6 AA1 7 LEU A 89 VAL A 94 -1 O LEU A 90 N CYS A 38 SHEET 7 AA1 7 VAL A 80 VAL A 86 -1 N SER A 84 O LYS A 91 SHEET 1 AA2 5 TYR A 104 PHE A 106 0 SHEET 2 AA2 5 VAL A 159 SER A 171 1 O PHE A 162 N THR A 105 SHEET 3 AA2 5 VAL A 151 ASN A 156 -1 N GLY A 152 O TYR A 164 SHEET 4 AA2 5 SER A 114 TYR A 121 -1 N LEU A 118 O VAL A 151 SHEET 5 AA2 5 LYS A 124 ASN A 132 -1 O PHE A 129 N VAL A 117 SHEET 1 AA3 3 TYR A 104 PHE A 106 0 SHEET 2 AA3 3 VAL A 159 SER A 171 1 O PHE A 162 N THR A 105 SHEET 3 AA3 3 THR A 174 SER A 178 -1 O THR A 176 N MET A 168 SHEET 1 AA4 7 ALA B 76 LEU B 78 0 SHEET 2 AA4 7 PHE B 66 LYS B 70 -1 N LYS B 70 O ALA B 76 SHEET 3 AA4 7 ILE B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 4 AA4 7 MET B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 THR B 35 PRO B 39 -1 O THR B 35 N LEU B 32 SHEET 6 AA4 7 LEU B 89 VAL B 94 -1 O LEU B 90 N CYS B 38 SHEET 7 AA4 7 VAL B 80 VAL B 86 -1 N SER B 84 O LYS B 91 SHEET 1 AA5 5 TYR B 104 PHE B 106 0 SHEET 2 AA5 5 ILE B 160 SER B 171 1 O PHE B 162 N THR B 105 SHEET 3 AA5 5 VAL B 151 GLU B 155 -1 N THR B 154 O ASN B 161 SHEET 4 AA5 5 SER B 114 TYR B 121 -1 N LEU B 118 O VAL B 151 SHEET 5 AA5 5 LYS B 124 ASN B 132 -1 O THR B 126 N ALA B 119 SHEET 1 AA6 3 TYR B 104 PHE B 106 0 SHEET 2 AA6 3 ILE B 160 SER B 171 1 O PHE B 162 N THR B 105 SHEET 3 AA6 3 THR B 174 SER B 178 -1 O THR B 174 N LEU B 170 SITE 1 AC1 2 GLU A 14 ASN A 15 SITE 1 AC2 4 ASP A 33 ASN A 98 THR A 101 ACT A 403 SITE 1 AC3 2 TRP A 236 ACT A 402 SITE 1 AC4 2 LYS A 201 TYR A 202 SITE 1 AC5 15 MET A 25 HIS A 41 LEU A 49 PHE A 143 SITE 2 AC5 15 LEU A 144 CYS A 145 CYS A 148 HIS A 166 SITE 3 AC5 15 MET A 168 GLU A 169 ASP A 190 LYS A 191 SITE 4 AC5 15 GLN A 192 HOH A 521 ASP B 47 SITE 1 AC6 3 ILE A 59 TYR B 104 HOH B 533 SITE 1 AC7 1 ASN B 15 SITE 1 AC8 2 ASP B 200 TYR B 202 SITE 1 AC9 14 MET B 25 HIS B 41 ALA B 46 LEU B 49 SITE 2 AC9 14 PHE B 143 LEU B 144 CYS B 148 HIS B 166 SITE 3 AC9 14 MET B 168 GLU B 169 ASP B 190 LYS B 191 SITE 4 AC9 14 GLN B 192 HOH B 506 CRYST1 57.799 87.534 112.991 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017301 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011424 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008850 0.00000